#survival-outcomes

[ follow ]
#glp-1-drugs #colon-cancer #inflammation #health-paradox #personalized-medicine #nutrition #chronic-disease
Public health
fromBusiness Insider
4 hours ago

Another perk of weight-loss drugs? Fewer colon cancer deaths, a study found

Colon cancer patients taking GLP-1 drugs like Ozempic or Mounjaro had about half the five-year risk of death compared with non-users.
fromwww.mercurynews.com
3 months ago

Cuomo's Paradox': Conditions considered unhealthy can promote disease but boost survival, UCSD scientist says

Factors like obesity, high cholesterol, and alcohol intake, often seen as harmful, may predict better survival in patients developing cancer or cardiovascular disease, highlighting the complexity of health and wellness.
Science
[ Load more ]